AWA
CTOR

Arkadios Wealth Advisors’s Citius Oncology CTOR Stock Holding History

Arkadios Wealth Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.58K Hold
11,666
– – ﹤0.01% 1758
2026
Q1 		$7.23K Hold
11,666
– – ﹤0.01% 1688
2025
Q4 		$11.7K Hold
11,666
– – ﹤0.01% 1558
2025
Q3 		$23.7K Hold
11,666
– – ﹤0.01% 1455
2025
Q2 		$50.7K Buy
+11,666
New +$13.6K ﹤0.01% 1285

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arkadios Wealth Advisors's CTOR Position: Q2 2026 in Review

Arkadios Wealth Advisors held its Citius Oncology (CTOR) position steady in Q2 2026 at 11,666 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

Arkadios Wealth Advisors first reported a position in CTOR in Q2 2025 and has held it in 5 quarters since. The position peaked at $50.7K in Q2 2025. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • Arkadios Wealth Advisors held 11,666 shares of Citius Oncology worth $7.58K as of Q2 2026.
  • Arkadios Wealth Advisors left its Citius Oncology share count unchanged in Q2 2026.
  • Citius Oncology made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1758 holding.
  • Arkadios Wealth Advisors first reported a position in Citius Oncology in Q2 2025 and has held it in 5 quarters since.
  • Arkadios Wealth Advisors's Citius Oncology position peaked at $50.7K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.